EYE 2.86% 18.0¢ nova eye medical limited

I should add that I think the E&P valuation is incredibly...

  1. 16,310 Posts.
    lightbulb Created with Sketch. 4359
    I should add that I think the E&P valuation is incredibly conservative. $31m is quite a low forecast for FY25, I would revise to $35m at least.

    Should have more clarification in the November sales update, which will highlight the value added by the new marketing team and what we can expect for FY25.

 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.